mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00064 |
1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.04 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |